This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2013-2026.
Company Filing History:
Years Active: 2013-2026
Title: Yuuichi Sugimoto: Innovator in Pharmaceutical Chemistry
Introduction
Yuuichi Sugimoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with anti-tumor activity. With a total of 12 patents to his name, Sugimoto's work is recognized for its potential impact on cancer treatment.
Latest Patents
Among his latest patents, Sugimoto has developed crystals of dispiropyrrolidine derivatives. These crystals include a dispiropyrrolidine compound or a salt thereof that inhibits the action of Mdm2. The invention provides crystals of a specific compound that has demonstrated anti-tumor activity. This compound is characterized by its complex chemical structure, which includes various functional groups that enhance its efficacy as a medicament.
Career Highlights
Yuuichi Sugimoto is currently associated with Daiichi Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His research focuses on creating effective treatments for cancer, leveraging his expertise in chemical compounds and their biological interactions.
Collaborations
Sugimoto has collaborated with notable colleagues in his field, including Shoko Yoshida and Kouichi Uoto. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Yuuichi Sugimoto's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the fight against cancer. His work continues to inspire advancements in medical treatments and showcases the importance of research in improving health outcomes.